Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ACRX - AcelRx Pharmaceuticals GAAP EPS of -$0.94 beats by $0.26 revenue of $0.51M misses by $0.12M

ACRX - AcelRx Pharmaceuticals GAAP EPS of -$0.94 beats by $0.26 revenue of $0.51M misses by $0.12M

AcelRx Pharmaceuticals Inc.
  • AcelRx Pharmaceuticals press release ( NASDAQ: ACRX ): Q3 GAAP EPS of -$0.94 beats by $0.26 .
  • Revenue of $0.51M (-72.6% Y/Y) misses by $0.12M .
  • Initial Niyad development batch successfully produced; preparations on track for an Emergency Use Authorization submission
  • DSUVIA sales of $0.5M in the third quarter, a 217% increase over prior year
  • $20.9 million in cash and short-term investments as of September 30, 2022.

For further details see:

AcelRx Pharmaceuticals GAAP EPS of -$0.94 beats by $0.26, revenue of $0.51M misses by $0.12M
Stock Information
Company Name: AcelRx Pharmaceuticals Inc.
Stock Symbol: ACRX
Market: NASDAQ
Website: acelrx.com
Menu
ACRX ACRX Quote ACRX Short ACRX News ACRX Articles ACRX Message Board
Get ACRX Alerts

News, Short Squeeze, Breakout and More Instantly...